The Individual Therapy for Patients With Wilson's Disease

Last updated: May 19, 2019
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Overall Status: Active - Recruiting

Phase

1

Condition

Wilson's Disease

Liver Disease

Liver Disorders

Treatment

N/A

Clinical Study ID

NCT03957720
WuZYLab-WD
  • All Genders

Study Summary

Based on the genotype characteristics and genotype-phenotype-treatment prognosis data of Chinese WD patients, this study intends to further optimize the treatment regimen of Chinese WD patients and formulate individualized treatment regimens for each genotype, so as to further improve the prognosis of patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Genetic diagnosis of Wilson's disease

  • Presymptomatic patients with Wilson's disease

Exclusion

Exclusion Criteria:

  • Movement disorder due to other definite causes instead of Wilson's disease

  • Severe Lung, kidney or liver disease

  • Neoplastic Disease

Study Design

Total Participants: 400
Study Start date:
March 15, 2019
Estimated Completion Date:
December 31, 2024

Study Description

The purpose of the study is to evaluate treatment regimen efficacy based on different mutations, and Zinc treatment in presymptomatic WD patients.

Connect with a study center

  • econd Affiliated Hospital,Zhejiang University School of Medicine

    Hangzhou, Zhejiang 310009
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.